186 related articles for article (PubMed ID: 22043277)
1. Importance of correlation between gene expression levels: application to the type I interferon signature in rheumatoid arthritis.
Reynier F; Petit F; Paye M; Turrel-Davin F; Imbert PE; Hot A; Mougin B; Miossec P
PLoS One; 2011; 6(10):e24828. PubMed ID: 22043277
[TBL] [Abstract][Full Text] [Related]
2. IRF4 and IRGs Delineate Clinically Relevant Gene Expression Signatures in Systemic Lupus Erythematosus and Rheumatoid Arthritis.
Rodríguez-Carrio J; López P; Alperi-López M; Caminal-Montero L; Ballina-García FJ; Suárez A
Front Immunol; 2018; 9():3085. PubMed ID: 30666255
[No Abstract] [Full Text] [Related]
3. Patients with systemic lupus erythematosus, myositis, rheumatoid arthritis and scleroderma share activation of a common type I interferon pathway.
Higgs BW; Liu Z; White B; Zhu W; White WI; Morehouse C; Brohawn P; Kiener PA; Richman L; Fiorentino D; Greenberg SA; Jallal B; Yao Y
Ann Rheum Dis; 2011 Nov; 70(11):2029-36. PubMed ID: 21803750
[TBL] [Abstract][Full Text] [Related]
4. Rheumatoid arthritis subtypes identified by genomic profiling of peripheral blood cells: assignment of a type I interferon signature in a subpopulation of patients.
van der Pouw Kraan TC; Wijbrandts CA; van Baarsen LG; Voskuyl AE; Rustenburg F; Baggen JM; Ibrahim SM; Fero M; Dijkmans BA; Tak PP; Verweij CL
Ann Rheum Dis; 2007 Aug; 66(8):1008-14. PubMed ID: 17223656
[TBL] [Abstract][Full Text] [Related]
5. Identification of activated cytokine pathways in the blood of systemic lupus erythematosus, myositis, rheumatoid arthritis, and scleroderma patients.
Higgs BW; Zhu W; Richman L; Fiorentino DF; Greenberg SA; Jallal B; Yao Y
Int J Rheum Dis; 2012 Feb; 15(1):25-35. PubMed ID: 22324944
[TBL] [Abstract][Full Text] [Related]
6. Novel biomarkers of a peripheral blood interferon signature associated with drug-naïve early arthritis patients distinguish persistent from self-limiting disease course.
Seyhan AA; Gregory B; Cribbs AP; Bhalara S; Li Y; Loreth C; Zhang Y; Guo Y; Lin LL; Feldmann M; Williams LM; Brennan FM; Taylor PC
Sci Rep; 2020 Jun; 10(1):8830. PubMed ID: 32483203
[TBL] [Abstract][Full Text] [Related]
7. Type I interferons have no major influence on humoral autoimmunity in rheumatoid arthritis.
Cantaert T; van Baarsen LG; Wijbrandts CA; Thurlings RM; van de Sande MG; Bos C; van der Pouw Kraan TC; Verweij CL; Tak PP; Baeten DL
Rheumatology (Oxford); 2010 Jan; 49(1):156-66. PubMed ID: 19933783
[TBL] [Abstract][Full Text] [Related]
8. The multifaceted balance of TNF-α and type I/II interferon responses in SLE and RA: how monocytes manage the impact of cytokines.
Smiljanovic B; Grün JR; Biesen R; Schulte-Wrede U; Baumgrass R; Stuhlmüller B; Maslinski W; Hiepe F; Burmester GR; Radbruch A; Häupl T; Grützkau A
J Mol Med (Berl); 2012 Nov; 90(11):1295-309. PubMed ID: 22610275
[TBL] [Abstract][Full Text] [Related]
9. Interferon gene expression signature in rheumatoid arthritis neutrophils correlates with a good response to TNFi therapy.
Wright HL; Thomas HB; Moots RJ; Edwards SW
Rheumatology (Oxford); 2015 Jan; 54(1):188-93. PubMed ID: 25125592
[TBL] [Abstract][Full Text] [Related]
10. Detection of gene expression signatures related to underlying disease and treatment in rheumatoid arthritis patients.
Serikawa KA; Jacobsen S; Lundsgaard D; Fox BA; Hummelshoj L; Poulsen LK; Fleckner J; Frederiksen KS
Mod Rheumatol; 2013 Jul; 23(4):729-40. PubMed ID: 22872428
[TBL] [Abstract][Full Text] [Related]
11. Regulation of IFN response gene activity during infliximab treatment in rheumatoid arthritis is associated with clinical response to treatment.
van Baarsen LG; Wijbrandts CA; Rustenburg F; Cantaert T; van der Pouw Kraan TC; Baeten DL; Dijkmans BA; Tak PP; Verweij CL
Arthritis Res Ther; 2010; 12(1):R11. PubMed ID: 20096109
[TBL] [Abstract][Full Text] [Related]
12. Relationship between the type I interferon signature and the response to rituximab in rheumatoid arthritis patients.
Thurlings RM; Boumans M; Tekstra J; van Roon JA; Vos K; van Westing DM; van Baarsen LG; Bos C; Kirou KA; Gerlag DM; Crow MK; Bijlsma JW; Verweij CL; Tak PP
Arthritis Rheum; 2010 Dec; 62(12):3607-14. PubMed ID: 20722020
[TBL] [Abstract][Full Text] [Related]
13. Modular transcriptional repertoire analyses of adults with systemic lupus erythematosus reveal distinct type I and type II interferon signatures.
Chiche L; Jourde-Chiche N; Whalen E; Presnell S; Gersuk V; Dang K; Anguiano E; Quinn C; Burtey S; Berland Y; Kaplanski G; Harle JR; Pascual V; Chaussabel D
Arthritis Rheumatol; 2014 Jun; 66(6):1583-95. PubMed ID: 24644022
[TBL] [Abstract][Full Text] [Related]
14. Functional assay of type I interferon in systemic lupus erythematosus plasma and association with anti-RNA binding protein autoantibodies.
Hua J; Kirou K; Lee C; Crow MK
Arthritis Rheum; 2006 Jun; 54(6):1906-16. PubMed ID: 16736505
[TBL] [Abstract][Full Text] [Related]
15. Identification of molecules associated with response to abatacept in patients with rheumatoid arthritis.
Yokoyama-Kokuryo W; Yamazaki H; Takeuchi T; Amano K; Kikuchi J; Kondo T; Nakamura S; Sakai R; Hirano F; Nanki T; Koike R; Harigai M
Arthritis Res Ther; 2020 Mar; 22(1):46. PubMed ID: 32164778
[TBL] [Abstract][Full Text] [Related]
16. Identification and stratification of systemic lupus erythematosus patients into two transcriptionally distinct clusters based on IFN-I signature.
Shobha V; Mohan A; Malini AV; Chopra P; Karunanithi P; Subramani Thulasingam S; Selvam S; Deyati A; Srivastava R; Basavanthappa S; Lemos N; Sunitha SM; Mazumder Tagore D; Anand A; Pant S; Jayaswal V; Ramarao M; Dudhgaonkar S
Lupus; 2021 Apr; 30(5):762-774. PubMed ID: 33497307
[TBL] [Abstract][Full Text] [Related]
17. The interferon-regulated gene signature is elevated in subacute cutaneous lupus erythematosus and discoid lupus erythematosus and correlates with the cutaneous lupus area and severity index score.
Braunstein I; Klein R; Okawa J; Werth VP
Br J Dermatol; 2012 May; 166(5):971-5. PubMed ID: 22242767
[TBL] [Abstract][Full Text] [Related]
18. An interferon signature in the peripheral blood of dermatomyositis patients is associated with disease activity.
Baechler EC; Bauer JW; Slattery CA; Ortmann WA; Espe KJ; Novitzke J; Ytterberg SR; Gregersen PK; Behrens TW; Reed AM
Mol Med; 2007; 13(1-2):59-68. PubMed ID: 17515957
[TBL] [Abstract][Full Text] [Related]
19. Interferon score is increased in incomplete systemic lupus erythematosus and correlates with myxovirus-resistance protein A in blood and skin.
Lambers WM; de Leeuw K; Doornbos-van der Meer B; Diercks GFH; Bootsma H; Westra J
Arthritis Res Ther; 2019 Dec; 21(1):260. PubMed ID: 31791398
[TBL] [Abstract][Full Text] [Related]
20. The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients.
Raterman HG; Vosslamber S; de Ridder S; Nurmohamed MT; Lems WF; Boers M; van de Wiel M; Dijkmans BA; Verweij CL; Voskuyl AE
Arthritis Res Ther; 2012 Apr; 14(2):R95. PubMed ID: 22540992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
